Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
China · Delayed Price · Currency is CNY 9.83
-0.15 (-1.50%)
Apr 28, 2026, 3:00 PM CST
SHA:600867 Market Cap
SHA:600867 has a market cap or net worth of 19.1 billion as of April 28, 2026. Its market cap has increased by 28.31% in one year.
Market Cap
19.10B
Enterprise Value
18.14B
Revenue
2.95B
Ranking
n/a
PE Ratio
15.85
Stock Price
9.83
Market Cap Chart
Since February 15, 2001, SHA:600867's market cap has increased from 3.86B to 19.10B, an increase of 394.74%. That is a compound annual growth rate of 6.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 19.40B | 22.15% |
| Dec 31, 2025 | 15.88B | 1.06% |
| Dec 31, 2024 | 15.71B | -26.86% |
| Dec 29, 2023 | 21.48B | 17.97% |
| Dec 30, 2022 | 18.21B | -17.83% |
| Dec 31, 2021 | 22.16B | -17.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apeloa Pharmaceutical Co.,Ltd | 21.16B |
| Jilin Aodong Pharmaceutical Group | 20.86B |
| Betta Pharmaceuticals | 20.79B |
| Wedge Industrial | 19.86B |
| Hybio Pharmaceutical | 19.78B |
| Joincare Pharmaceutical Group Industry | 19.42B |
| Walvax Biotechnology | 19.11B |
| China Resources Double-Crane Pharmaceutical | 18.40B |